Repository

of Grodno State Medical University

ISSN (online): 2523-4722

Evaluating the impact of bevacizumab as a targeted therapy in combination with standard chemotherapy on disease progression and treatment outcomes in ovarian cancer

Files in this item

This item appears in the following Collection(s)

Search DSpace


Browse

My Account

Statistics